does glp 1 treat insulin resistance The GLP-1 Era Has Changed Obesity Treatment. Semaglutide & Tirzepatide are redefining the management of: • Obesity • Type 2 Diabetes • • Metabolic Syndrome Clinical benefits may include: ✓ GLP-1 Therapy for Type 2

Nevertheless, given the limitations of current evidence, robust randomized controlled trials with larger cohorts and longer follow-up are necessary to confirm these outcomes and further elucidate the therapeutic implications of GLP-1 RAs in hormonal regulation

McGraw-Hill / Lange rxlist.com (Adlyxin ) Albiglutide Drug Name: Tanzeum (FDA Approved 4/15/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 4-7 days) subcutaneous pen injections weekly or biweekly (vs daily for other GLP-1 agonists)

Long-acting preparations also include semaglutide (SMG), dulaglutide (DUL), long-acting release formulation of exenatide (EX-LAR), and polyethylene glycol loxenatide (PEX-168), which generally need to be injected once a week

Integrating these exercise strategies with nutritional support is essential to preserve muscle mass, reduce fatigue, and maximize the benefits of GLP-1RA therapy (62)